Red Fluorescent PC-3 Cell Line (aka VAMPIRO PC-3) has been developed through stable transfection of PC-3 cell line with tFP602. This cell line expresses true-red fluorescent protein gene sequences as free cytoplasmatic proteins. Each vial of cells contains more than 3 million viable cells stably expressing tFP602 with Puromycin resistance gene:
VAMPIRO PC-3 Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. Red Fluorescent PC-3 Cell Line also allows to stablish in vitro models for High Throughput and High Content Screening.
Red Fluorescent SH-SY5Y Cell Line (aka VAMPIRO SH-SY5Y) has been developed through stable transfection of SH-SY5Y cell line with tFP602. This cell line expresses red fluorescent protein gene sequences as free cytoplasmatic proteins. Each vial of cells contains more than 3 million viable cells stably expressing tFP602 with G418 resistance gene:
VAMPIRO SH-SY5Y Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. Red Fluorescent SH-SY5Y Cell Line also allows to stablish in vitro models for High Throughput and High Content Screening.
Red Fluorescent SK-BR-3 Cell Line (aka VAMPIRO SK-BR-3) has been developed through stable transfection of SK-BR-3 cell line with tFP602. This cell line expresses red fluorescent protein gene sequences as free cytoplasmatic proteins. Each vial of cells contains more than 3 million viable cells stably expressing tFP602 with G418 resistance gene:
VAMPIRO SK-BR-3 Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. Red Fluorescent SK-BR-3 Cell Line also allows to stablish in vitro models for High Throughput and High Content Screening.
Red Fluorescent U2OS Cell Line (aka VAMPIRO U2OS) has been developed through stable transfection of U2OS cell line with tFP602. This cell line expresses red fluorescent protein gene sequences as free cytoplasmatic proteins. Each vial of cells contains more than 3 million viable cells stably expressing tFP602 with puromycin resistance gene:
VAMPIRO U2OS Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. Red Fluorescent U2OS Cell Line also allows to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV Spike Glycoprotein Cell Line from Innoprot has been developed stably transfecting HEK293T cell line with a SARS-CoV Spike Glycoprotein expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV Spike Glycoprotein in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV Spike Glycoprotein with hygromycin resistance gene.
SARS-CoV Spike Glycoprotein Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV Spike Glycoprotein HEK293T Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV-2 Membrane Protein Cell Line from Innoprot has been developed stably transfecting HEK293 cell line with a SARS-CoV-2 Membrane Protein expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV-2 Membrane protein. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV-2 Membrane Protein with hygromycin resistance gene.
SARS-CoV-2 Membrane Protein Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV-2 Membrane Protein HEK293 Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV-2 Nucleocapsid Protein Cell Line from Innoprot has been developed stably transfecting HEK293 cell line with a SARS-CoV-2 Nucleocapsid expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV-2 Nucleocapsid protein. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV-2 Nucleocapsid Protein with hygromycin resistance gene.
SARS-CoV-2 Nucleocapsid Protein Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV-2 Nucleocapsid Protein HEK293 Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV-2 Spike D614G mutant Cell Line from Innoprot has been developed stably transfecting HEK293 cell line with a SARS-CoV-2 Spike D614G mutant expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV-2 Spike D614G mutant in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV-2 Spike D614G mutant with hygromycin resistance gene.
SARS-CoV-2 Spike D614G mutant Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV-2 Spike D614G mutant Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV-2 Spike Glycoprotein Cell Line from Innoprot has been developed stably transfecting HEK293T cell line with a SARS-CoV-2 Spike Glycoprotein expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV-2 Spike Glycoprotein in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV-2 Spike Glycoprotein with hygromycin resistance gene.
SARS-CoV-2 Spike Glycoprotein Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV-2 Spike Glycoprotein HEK293T Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV-2 Spike V367F mutant Cell Line from Innoprot has been developed stably transfecting HEK293 cell line with a SARS-CoV-2 Spike V367F mutant expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV-2 Spike V367F mutant in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV-2 Spike V367F mutant with hygromycin resistance gene.
SARS-CoV-2 Spike V367F mutant Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV-2 Spike V367F mutant Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
SARS-CoV-2 Spike V483A mutant Cell Line from Innoprot has been developed stably transfecting HEK293 cell line with a SARS-CoV-2 Spike V483A mutant expression plasmid. This cell line provides consistent levels of expression of human SARS-CoV-2 Spike V483A mutant in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing SARS-CoV-2 Spike V483A mutant with hygromycin resistance gene.
SARS-CoV-2 Spike V483A mutant Cell line is ready to use in cell-based assay applications. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. SARS-CoV-2 Spike V483A mutant Cell line also allow to stablish in vitro models for High Throughput and High Content Screening.
Schwann Cell Medium Kit is a complete medium designed for optimal growth of normal primary Schwann Cells in vitro. Each Schwann Cell Medium Kit consists of the next components:
Sertoli Cell Medium Kit is a complete medium designed for optimal growth of normal primary Sertoli Cells in vitro. Each Sertoli Cell Medium Kit consists of the next components:
A novel SH‐SY5Y cell line has been developed through stable transfection with tGPF‐tau protein (0N4R isoform-G272V mutation) and TagRFP‐α‐synuclein (wild type). This cell line is stably‐transfected with both construcst and it is ready to use in cell‐based assay applications. This stably transfected cell line provides consistent levels of expression, which helps to simplify the interpretation of the results. This cell line is intended to be used as an “in vitro” model for research studies.
Each vial of this cell line stably expressing human tau(0N4R-G272V)-tGFP and TagRFP‐α‐synuclein contains 3 million cells. It is guaranteed that these cells will expand in more than 30 passages following the cell culture manual.
Skeletal Muscle Cell Medium Kit is a complete medium designed for optimal growth of normal primary Skeletal Muscle Cells in vitro. Each Skeletal Muscle Cell Medium Kit consists of the next components:
Small Airway Epithelial Cell Medium Kit is a complete medium designed for optimal growth of normal human Small Airway epithelial cells in vitro. Each Small Airway Epithelial Cell Medium Kit consists of the next components:
500 ml of Small Airway Epithelial Cell basal medium
5 ml of Small Airway Epithelial Cell Growth Supplement
